Stabenow, other state leaders to sound alarm against the competitive procurement process for prepaid inpatient health plansLANSING, Mich., Sept. 04,...
Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded...
ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis...
Illustrative image Laboratory, Boehringer Ingelheim This press release is not intended for UK and US media. HERNEXEOS® (zongertinib tablets) has been...
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke...
OAKLAND PARK, FL / ACCESS Newswire / August 24, 2025 / EndoUVTech, a medical device innovator pioneering UV laser technology...
WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage...
WALTHAM, Mass., DUBLIN, Ireland and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage...
Combining intelligent tools and personalized support, RethinkCare empowers employers, families and caregivers with clinically validated resources, expert coaching and navigation...
ENX-CL-05-001 Trial: 3-months topline data -Â Â Â In the overall modified intention-to-treat (mITT) population, improvements across all efficacy and secondary endpoints, including...
Medical Records Summarization (MRS) for bodily injury claims integrates AI automation with expert analysis to hasten claims resolution SAN DIEGO,...
PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on...
PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on...
Class Actions Seeks to Represent Untold Number of Caregivers Who Appealed Denials from the VA's Program of Comprehensive Assistance for...
CONSHOHOCKEN, Pa., Aug. 12, 2025 /PRNewswire/ -- ActiveProtective® is proud to announce the FDA-authorized breakthrough medical device the Tango® Belt...
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
– Global, pivotal Phase 3 study will evaluate efficacy and safety of zorevunersen compared to sham over a 52-week treatment...
Innovating for the Public Good Reveals the Red Tape Barriers to Social Safety Net Programs,Increased by One Big Beautiful Bill...
RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency...
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13)Updates 2025 projected...